Sandrine Sotton
Papers
1
Total Citations
7
H-Index
1
About
Sandrine Sotton is a health economist whose work bridges the gap between cutting-edge oncology and real-world healthcare decision-making. Her research focuses on the economic evaluation of advanced cancer treatments, with a particular emphasis on robotic-assisted technologies for prostate cancer—the most common cancer among men in France. In her landmark 2022 study, Sotton conducted a rigorous cost-utility analysis comparing robot-assisted radical prostatectomies (rRP) against robotic stereotactic body radiotherapy (rSBRT), providing critical insights into both the clinical and economic impacts of these competing modalities. This work, which has garnered 7 citations, is notable for its practical relevance to healthcare systems grappling with the high costs of robotic surgery and radiotherapy. By quantifying value in terms of both patient outcomes and financial sustainability, Sotton’s research empowers clinicians and policymakers to make evidence-based choices. Her contributions are especially timely as robotic technologies become more widespread, ensuring that innovation is paired with fiscal responsibility. For students and researchers, Sotton exemplifies how health economics can translate complex clinical advances into actionable strategies for improving cancer care.
Research Focus
Key Achievements
Top Papers
- 1